Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure-Reference-Cited by-同舟云学术

Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure

Published:2009-02 Issue:1 Volume:6 Page:67-72
ISSN:1742-4801
Container-title:International Wound Journal
language:en
Short-container-title:

Author:

Fernández-Montequín José I,Betancourt Blas Y,Leyva-Gonzalez Gisselle,Mola Ernesto L,Galán-Naranjo Katia,Ramírez-Navas Mayte,Bermúdez-Rojas Sergio,Rosales Felix,García-Iglesias Elizeth,Berlanga-Acosta Jorge,Silva-Rodriguez Ricardo,Garcia-Siverio Marianela,Martinez Luis H

Publisher

Wiley

Subject

Dermatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-481X.2008.00561.x/fullpdf

Reference24 articles.

1. American College of Foot and Ankle Surgeons. Diabetic foot disorders. A clinical practice guideline (2006 revision);Frykberg;J Foot Ankle Surg,2006

2. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort;Abbott;Diabet Med,2002

3. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration;Abbott;Diabetes Care,1998

4. The global burden of diabetic foot disease;Boulton;Lancet,2005

5. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study;Wieman;Diabetes Care,1998

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the Potency of Growth Factors in Bovine Colostrum;Nutrients;2024-07-21

2. Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infection;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-19

3. Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial;Frontiers in Neurology;2024-04-04

4. The effect of human recombinant epidermal growth factor on neovascularization and pedicle division time in a rat interpolation flap model;Turkish Journal of Medical Sciences;2024-04-03

5. Functional characterization of the dimeric form of PDGF-derived fusion peptide fabricated based on theoretical arguments;Scientific Reports;2024-01-10